510(k) Report

FDA applicant

Vancouver Biotech, Ltd.

Northridge, CA2 decisions2003–20050 recalls

FDA records 2 decisions for Vancouver Biotech, Ltd. (Northridge, CA) from 2003 to 2005: 2 510(k) clearances. All are in product code MMI (Immunoassay Method, Troponin Subunit). No recall is linked to its devices.

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) refreshed weekly, last Nov 3, 2026

FIG. A — Illustration, clinical chemistry panel, where it files most

How often FDA has decided Vancouver Biotech, Ltd.’s devices, and how often a recall has named them.

FDA decisions per year

No FDA decision for Vancouver Biotech, Ltd. since 2007.

Recalls per year

No recall linked to its devices since 2007.

FIG. 1 — Vancouver Biotech, Ltd. by year, 2007–2026Sources: FDA decision databases, recall and enforcement reports · Data through Oct 25, 2026

Planning a device like Vancouver Biotech, Ltd.’s? A 510(k) Report ranks candidate predicates for your device by lineage, citations and recall history, with the review-time outlook.

See the 510(k) Report

Which product codes does it file in?

  • MMIImmunoassay Method, Troponin Subunit2decisions

Who builds on its devices?

Later devices cite its devices 2 times; 0 of those are its own. The firms that cite it most:

Which of its devices are cited most?

Its devices that later submissions most often claim equivalence to.

  • K023505VBL Serum Troponin I Test, Model 1001Vancouver Biotech, Ltd. · 20032cite it

What has FDA decided for it lately?

  • K050644Vancouver Biotech Human Cardiac Troponin I Immunoassay Test KitVancouver Biotech, Ltd. · 2005
  • K023505VBL Serum Troponin I Test, Model 1001Vancouver Biotech, Ltd. · 2003

All 2 as Vancouver Biotech, Ltd. →

Other applicant names beginning “Vancouver”

FDA records each applicant name separately; these may or may not be the same firm.

Vancouver Implant Resources, Inc. 6Vancouver Implant Center 3